Stock listing
Maze Therapeutics, Inc.
Selected listing: MAZE · NASDAQ · USD · US
Maze Therapeutics, Inc. (NASDAQ:MAZE), Health Technology. Latest release Oct 6, 2026: Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN…
- Ticker
- NASDAQ:MAZE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Maze Therapeutics, Inc.
Maze Therapeutics, Inc. is a public company listed under the ticker MAZE, operating in the American market. Maze Therapeutics focuses on developing innovative therapies to address genetic diseases.
Latest news from Maze Therapeutics, Inc.
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
October 6, 2026
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
September 2, 2026
Maze Therapeutics Announces Appointments to Its Board of Directors
August 13, 2026
Maze Therapeutics Announces $150 Million Registered Offering
April 22, 2026
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
March 24, 2026
Events
Replays
Maze Therapeutics, Inc. (MAZE) Q4 2025 Earnings Call
Wed, Mar 25, 2026 · 08:00 AM ET
Watch
Research Maze Therapeutics, Inc.
Maze Therapeutics, Inc. company profile
View the public company page for Maze Therapeutics, Inc. on 6ix.
Maze Therapeutics, Inc. news
Read company news and market updates connected to Maze Therapeutics, Inc..
Maze Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Maze Therapeutics, Inc..